Liquidia Corp (LQDA) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US53635D2027
Liquidia Corp financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 158.32 m USD |
| Operating income | -51.38 m USD |
| EBIT | -51.38 m USD |
| Net income | -68.92 m USD |
| Diluted EPS – continuing operations | -0.80 USD |
Full history since 2016, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Liquidia Corp
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States. The company's lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also provides Remodulin, a treprostinil injection administered through continuous intravenous and subcutaneous infusion; and develops L606, an investigational liposomal formulation of treprostinil which is in phase III clinical trial for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). In addition, the company offers PRINT technology which allows to engineer and manufacture uniform drug particles with precise control over the size, three-dimensional geometric shape, and chemical composition of the particles. It has a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD; Vectura; The University of North Carolina at Chapel Hill; GlaxoSmithKline; Alcon Inc; and promotion Agreement with Sandoz. Liquidia Corporation was founded in 2004 and is based in Morrisville, North Carolina.
More stocks
- Santen Pharmaceutical Co Ltd (4536.T)
- INDEPENDENCE REALTY TRUST, INC. (IRT)
- Nikon Corp (7731.T)
- Ferrotec (Anhui) Technology Development Co. Ltd. A (301297.SZ)
- Koei Tecmo Holdings Co Ltd (3635.T)
- NICOLET BANKSHARES INC (NIC)
- Focuslight Technologies Inc. A (688167.SS)
- Shanxi Coal International Energy Group Co Ltd (600546.SS)
- Valeo SE (FR.PA)
- GEO GROUP INC (GEO)
- Henzhen Zhaowei Machinery And Elect (003021.SZ)
- Beijing Sifang Automation Co Ltd (601126.SS)
Not investment advice. All data without warranty, price as of 22.10.2026. Details in the risk notice.